Galway Bay fm newsroom - €30m in funding has been announced for MedTech and Lifesciences projects based in Galway.
It's part of a national allocation of €95m under the Government's Disruptive Technologies Fund, which aims to support innovative projects that lead to high-quality jobs.
The largest allocation of €7m has been awarded to a project led by city-based Medtech Revelium - to support a regenerative treatment for knee osteoarthritis, using a hydrogel-based therapeutic.
Other allocations to projects based in Galway - involving multiple local and national medtech firms - cover a wide range of applications
They range from a project to offer fast, reliable drone delivery, to advanced heart valve replacements, and next-gen treatments for gastrointestinal and lung cancers.
Also awarded funding is a project to develop the world's first pain-free, patient-led treatment to prevent Chemotherapy Induced Alopecia.
In total, nine projects based in Galway are to share an allocation of €30.24m.
